In Silico Design of a Multivalent Epitope Vaccine Against SARS-CoV-۲ for Iranian Populations
محل انتشار: مجله تحقیق در پزشکی مولکولی، دوره: 9، شماره: 4
سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 39
فایل این مقاله در 16 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_REMJ-9-4_002
تاریخ نمایه سازی: 20 دی 1402
چکیده مقاله:
Background: Because of high genetic variation in human leukocyte antigen (HLA) alleles, epitope-based vaccines do not show equal efficacy in different human populations. Therefore, we proposed a multi-epitope vaccine against SARS-CoV-۲ (severe acuterespiratory syndrome coronavirus ۲) for Iranian populations.
Materials and Methods: For this purpose, the proteins without allergenicity and high antigenicity, as well as conservancy levels from SARS-CoV-۲, were chosen for computational epitope mapping. The T-cell epitope mapping process was performed based on the most frequent human leukocyte antigen (HLA) alleles in Iran. The B- and T-cell epitopes were determined based on their allergenicity, antigenicity, and hemolytic potential. Then, the epitopes with acceptable features were subjected to the final construct. The screened epitopes were structured in the final vaccine sequence. The secondary and tertiary structures of the proposed vaccine were predicted, and its affinity to HLA-I, HLA-II, toll-like receptor (TLR)-۳, and TLR-۴ were evaluated by the molecular docking method. Additionally, possible immune responses against the vaccine were predicted through immune simulation.
Results: The final vaccine construct includes six linear B-cell epitopes, eight HLA-I restricted epitopes, and six HLA-II restricted epitopes. The evaluations confirmed that the proposed vaccine is a ۶۰.۳ kDa stable, water-soluble, and high antigenic protein with high affinity to the selected target molecules and could elicit both humoral and cellular responses.
Conclusion: Altogether, the study results suggest that the planned vaccine can be an adequate anti-COVID-۱۹ vaccine candidate for the Iranian population.
کلیدواژه ها:
نویسندگان
Faezeh Soltanveis
۱Department of Biology, Payame Noor University, Tehran, Iran
Mokhtar Nosrati
Independent researcher
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :